Form 4: Quipt Home Medical Exec Sells Shares in Acquisition

Quipt Home Medical Corp. Executive VP Operations, Patrick Dennis Gamble, disposed of all his common shares and stock options as part of a plan of arrangement where the company was acquired for $3.65 per share.

Summary

• Patrick Dennis Gamble, Executive VP Operations of Quipt Home Medical Corp. (QIPT), reported changes in beneficial ownership related to the company's acquisition.
• On March 16, 2026, Quipt Home Medical Corp. is set to be acquired by 1567208 B.C. LTD and REM Aggregator, LLC (collectively, 'Purchaser') under a plan of arrangement.
• Under the arrangement, each common share (excluding those of Dissenting Shareholders) will be transferred to the Purchaser for a cash payment of US$3.65 per share, without interest.
• Restricted Share Units (RSUs) outstanding immediately prior to the Effective Time will be transferred to the Issuer for a cash payment of US$3.65 per unit, less any required tax withholdings.
• Stock options outstanding immediately prior to the Effective Time will become unconditionally vested and exercisable, then surrendered for a cash payment equal to the excess of US$3.65 over the option's exercise price, less taxes.
• Any stock options with an exercise price equal to or greater than US$3.65 will be cancelled for no consideration.
• Gamble disposed of 60,057 common shares at US$3.65 per share.
• Gamble also disposed of 15,000 stock options with an exercise price of US$6.14, which were cancelled for no consideration as the exercise price exceeded the acquisition price.
• Following these transactions, Gamble will beneficially own 0 common shares and 0 derivative securities.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event for the market, as it represents the finalization of an acquisition. While shareholders received cash, some option holders experienced a loss.

Positives

• Shareholders (excluding dissenters) will receive a fixed cash payment of US$3.65 per common share, providing liquidity and a defined exit value.
• Holders of Restricted Share Units (RSUs) will receive US$3.65 per unit in cash, less taxes, converting their equity awards into liquid assets.
• Holders of in-the-money stock options (exercise price below US$3.65) will receive a cash payment for the intrinsic value of their options.

Negatives

• Stock options with an exercise price equal to or greater than US$3.65, such as Patrick Dennis Gamble's 15,000 options at US$6.14, will be cancelled for no consideration, resulting in a loss of potential value for those holders.
• The acquisition means Quipt Home Medical Corp. will cease to be an independent publicly traded entity, limiting future investment opportunities in the standalone company.

Risks

• Shareholders who properly exercise dissent rights under the Business Corporations Act (British Columbia) may not receive the US$3.65 per share, potentially leading to valuation disputes or legal proceedings.
• Cash payments for RSUs and stock options are subject to tax withholdings, which could impact the net proceeds received by holders.

Future Outlook

The filing indicates the completion of an acquisition, meaning Quipt Home Medical Corp. will no longer operate as an independent public entity. The future outlook for the company as a standalone entity is therefore limited, as it will be integrated into the acquiring entities.

Industry Context

StockSavvy.ai notes that the healthcare services and medical equipment industry frequently experiences consolidation, with larger entities acquiring specialized providers like Quipt Home Medical Corp. This acquisition at US$3.65 per share reflects a valuation agreed upon by the parties involved, likely driven by strategic synergies or market positioning within the sector.

Comparison to Industry Standards

• The acquisition price of US$3.65 per share would need to be benchmarked against recent M&A multiples (e.g., Enterprise Value/EBITDA, Price/Sales) for comparable home medical equipment providers or healthcare service companies.
• For instance, recent transactions in the durable medical equipment (DME) sector, such as the acquisition of AdaptHealth Corp. by a private equity firm or other strategic buyers, would provide a relevant comparison for valuation metrics.
• Without specific financial data for Quipt Home Medical Corp. or detailed comparable transaction information, a precise assessment against industry standards is limited.

Corporate Governance

Legal Proceedings

• Potential for legal proceedings related to dissent rights exercised by shareholders under the Business Corporations Act (British Columbia).

Stakeholder Impact

• Shareholders: Will receive US$3.65 per share in cash, providing liquidity and a defined exit value for their investment.
• Option Holders: Those with in-the-money options will receive cash for their intrinsic value; those with out-of-the-money options will have them cancelled for no consideration.
• Employees: The acquisition may lead to changes in organizational structure, management, and employment terms, though specific details are not provided in this filing.
• Customers/Suppliers: Potential changes in operational strategies, product offerings, or business relationships post-acquisition.

Next Steps

• Integration of Quipt Home Medical Corp. into the acquiring entities (1567208 B.C. LTD and REM Aggregator, LLC) following the effective date.
• Processing of cash payments to eligible shareholders, RSU holders, and option holders.
• Resolution of any dissent rights properly exercised by shareholders under the Business Corporations Act (British Columbia).

Key Dates

Keywords

Quipt Home Medical Corp, QIPT, SEC Form 4, Insider Transaction, Acquisition, Plan of Arrangement, Common Shares, Stock Options, Restricted Share Units, Merger, Executive Compensation, Beneficial Ownership